R and D Investor Day (Novartis) - Nov 8, 2012 - Anticipated data read-out from pivotal study for metabolic diseases by October 2013; Anticipated filing in EU and US for metabolic diseases in between November 2013-October 2014
Anticipated clinical data • Anticipated EU regulatory • Anticipated FDA event • Dyslipidemia
|